GWEN M ZHOU

Allopathic & Osteopathic Physicians|Family Medicine OMAHA, NE NPI 1982804522

General Payments — all program years on this page

$325.83

  • Category: General Payments
  • Program years: PY2018
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2018): $325.83 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2018) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $325.8323

By paying entity

Latest program year (PY2018) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $325.8323

Records — PY2018 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
559331869 Lilly USA, LLC $11.40 02/05/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
559951884 AstraZeneca Pharmaceuticals LP $11.73 02/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
560535657 AstraZeneca Pharmaceuticals LP $10.56 04/04/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
566651187 Shire North American Group Inc $11.45 04/02/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567314529 Amgen Inc. $13.01 01/10/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567314533 Amgen Inc. $11.73 02/02/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567314535 Amgen Inc. $12.14 04/10/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
567314539 Amgen Inc. $11.79 04/24/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589039243 Novo Nordisk Inc $14.04 03/02/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589039249 Novo Nordisk Inc $13.97 04/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589039253 Novo Nordisk Inc $13.24 01/19/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589039255 Novo Nordisk Inc $12.57 02/16/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589663781 Takeda Pharmaceuticals U.S.A., Inc. $15.85 01/25/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589726851 Takeda Pharmaceuticals U.S.A., Inc. $19.77 03/01/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
589796346 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.15 03/28/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
593543967 GlaxoSmithKline, LLC. $13.69 02/01/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
593545117 GlaxoSmithKline, LLC. $13.69 03/09/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
593642336 GlaxoSmithKline, LLC. $16.89 03/21/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
594061621 GlaxoSmithKline, LLC. $15.35 03/20/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
596206795 Allergan Inc. $20.99 01/18/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
602056741 Sanofi Pasteur Inc. $16.66 02/15/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
604796875 Merck Sharp & Dohme Corporation $15.56 01/09/2018 Food and Beverage Undisputed 01/23/2026 View at CMS
608885273 Novartis Pharmaceuticals Corporation $10.60 03/27/2018 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.